Buy Fuvestrol : Fulvestrant 250 Mg Injection Online

Description

Description:

Fuvestrol is a medication containing the active substance fulvestrant. It is used primarily in the treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer in postmenopausal women who have not responded to other treatments. Fulvestrant belongs to a class of drugs known as estrogen receptor antagonists, which work by blocking the action of estrogen in breast tissue.

Key Points:

• Active Ingredient:
  • Fulvestrant: A selective estrogen receptor degrader (SERD) that binds to and downregulates estrogen receptors (ER) in breast cancer cells, inhibiting estrogen signaling and leading to cell cycle arrest and apoptosis.
• Indications:
  • Fuvestrol is indicated for the treatment of hormone receptor-positive (HR+), HER2-negative advanced breast cancer in postmenopausal women who have experienced disease progression following prior endocrine therapy.
• Mechanism of Action:
  • Fulvestrant acts as a competitive inhibitor of estrogen by binding to and downregulating estrogen receptors (ER) in breast cancer cells. It induces degradation of ERα and prevents estrogen-mediated transcriptional activity, ultimately inhibiting the growth of estrogen-dependent breast cancer cells.
• Dosage Form:
  • Fuvestrol is available as a sterile solution for intramuscular injection, typically supplied in vials containing a specific dosage strength of 250 mg of fulvestrant.
• Dosage and Administration:
  • The recommended dosage of Fuvestrol is 500 mg (two 250 mg injections) administered as two separate injections into the buttocks on days 1 and 15 of the treatment cycle, followed by a maintenance dose of 500 mg once monthly. The injections should be administered by a healthcare professional trained in intramuscular injection techniques.
• Precautions:
  • Fuvestrol should be used with caution in patients with hepatic impairment, as fulvestrant is predominantly metabolized in the liver. Close monitoring of liver function tests is recommended during treatment.
• Possible Side Effects:
  • Common side effects of fulvestrant may include injection site reactions (pain, swelling, redness), nausea, vomiting, headache, fatigue, hot flashes, and musculoskeletal pain. Serious adverse reactions such as thromboembolic events, hepatotoxicity, and hypersensitivity reactions may occur and require medical attention.
• Manufacturer:
  • Fuvestrol is manufactured by Cadila Pharmaceuticals Ltd., a reputable pharmaceutical company known for its high-quality medications and commitment to patient care.

Note: Fuvestrol offers an effective treatment option for postmenopausal women with hormone receptor-positive advanced breast cancer who have progressed on prior endocrine therapy. Patients receiving Fuvestrol should be closely monitored for treatment response and adverse reactions, and appropriate supportive care measures should be implemented as needed. It is important for healthcare providers to educate patients about the potential risks and benefits of Fuvestrol therapy and to address any questions or concerns they may have regarding treatment.